Your session is about to expire
← Back to Search
ICARE Motor-Assisted Elliptical Training for Neurological Disorders
N/A
Waitlist Available
Led By Judith M. Burnfield, Ph.D.
Research Sponsored by Madonna Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Walking dysfunction from a neurologic injury or illness (e.g. stroke, brain injury, incomplete spinal cord injury, multiple sclerosis, Parkinson's disease, cerebral palsy);
Able to stand (with or without a standing frame) for at least 5 minutes at a time
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 50 minutes
Awards & highlights
Study Summary
This trial will test if using a motor-assisted elliptical in both forward and reverse modes can help improve gait and cardiorespiratory fitness.
Who is the study for?
This trial is for individuals with walking difficulties due to neurological injuries or illnesses like stroke, brain injury, spinal cord injury, multiple sclerosis, Parkinson's disease, or cerebral palsy. Participants must be able to stand for at least 5 minutes and follow simple commands. Those in other therapy/exercise programs, with unhealed bone fractures/breaks, unstable heart/lung conditions, pregnant women or those experiencing pain that limits walking are excluded.Check my eligibility
What is being tested?
The study tests whether using the ICARE (motor-assisted elliptical) in both forward and reverse modes can improve walking ability and cardio fitness in people with neurological disorders. It compares the effects of starting training with either reverse or forward movements on gait and cardiovascular health.See study design
What are the potential side effects?
While not explicitly mentioned here, potential side effects may include muscle soreness or fatigue from exercise on the ICARE trainer. There could also be a risk of falls if balance is affected during use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have difficulty walking due to a neurological condition.
Select...
I can stand for at least 5 minutes, with or without support.
Select...
I can stand for at least 5 minutes, with or without support.
Select...
I have difficulty walking due to a neurological condition.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 50 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 50 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
10 Meter Walk Test Speed
Peak Oxygen Consumption
Secondary outcome measures
6 Minute Walk Test
Cardiorespiratory Response During ICARE Training
Cardiorespiratory Response During Treadmill Walking
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Reverse First ICARE TrainingExperimental Treatment1 Intervention
Participants will engage in 12-sessions in the reverse direction followed by 12-sessions in the forward direction.
Group II: Forward First ICARE TrainingExperimental Treatment1 Intervention
Participants will engage in 12-sessions in the forward direction followed by 12-sessions in the reverse direction.
Find a Location
Who is running the clinical trial?
Madonna Rehabilitation HospitalLead Sponsor
2 Previous Clinical Trials
180 Total Patients Enrolled
Judith M. Burnfield, Ph.D.Principal Investigator - Madonna Rehabilitation Hospital
Madonna Rehabilitation Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have difficulty walking due to a neurological condition.I have an unhealed bone fracture or break.I can safely use the ICARE trainer with my current mental and communication skills.I do not have heart or lung conditions that make exercise unsafe.I can understand and follow simple instructions.I can stand for at least 5 minutes, with or without support.I can understand and follow simple instructions.I experience pain that stops me from walking or exercising.I can stand for at least 5 minutes, with or without support.I have difficulty walking due to a neurological condition.I can safely use the ICARE trainer with my current mental and communication skills.
Research Study Groups:
This trial has the following groups:- Group 1: Reverse First ICARE Training
- Group 2: Forward First ICARE Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are new recruits still being welcomed for this clinical experiment?
"As per the most recent amendment on April 20th 2022, this clinical trial is still recruiting participants. It was initially posted to clinicaltrials.gov on June 1st 2018."
Answered by AI
How many participants are being accepted into this medical trial?
"Indeed, the details on clinicaltrials.gov suggest that this trial is actively recruiting patients. It was initially published on June 1st 2018 and last modified April 20th 2022, with the aim of obtaining 60 participants from a single site."
Answered by AI
What is the primary objective of this medical investigation?
"This clinical trial will span a duration of up to 30 minutes, and aims primarily to evaluate 10 Meter Walk Test Speed. Auxiliary objectives include the 6 Minute Walk Test (to measure aerobic capacity), Cardiorespiratory Response During Treadmill Walking (rates of perceived effort during exercise testing) and Timed Up and Go (TUG) Test (time taken for standardized mobility balancing)."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger